The Africa Go-to-Market Model: Why Copy-Paste from Emerging Markets Fails — and What to Build Instead
Pharma companies entering African markets frequently rely on commercial models borrowed from other emerging markets — Latin America, South-East Asia, Eastern Europe — and are surprised when they underperform. Sub-Saharan and North African markets require purpose-built GTM architectures that account for channel fragmentation, regulatory heterogeneity, and informal distribution dynamics that simply do not exist elsewhere.
Read More